share_log

Piper Sandler Maintains Underweight on Vapotherm, Lowers Price Target to $2

Benzinga Real-time News ·  Aug 4, 2022 06:48

Piper Sandler analyst Jason Bednar maintains Vapotherm (NYSE:VAPO) with a Underweight and lowers the price target from $2.5 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment